IP Library Granted Patent US 7,244,427
Granted Patent B2
US 7,244,427 · App. 09/772,603 · Granted Jul 17, 2007

Isolated bovine IgG heavy chain protein and its use as an antimicrobial

Assignee: The Lauridsen Group Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,244,427
App. No.
09/772,603
Granted
Jul 17, 2007
Kind
B2
Abstract

A new protein derived from acid hydrolyzed IgG concentrate which has a molecular weight of about 55,000, and is activated by heat within the defined narrow temperature range provides resulting product that has a protective mechanism for bacterial and viral invasion of living cells.

Claims (4)

1. A method of providing bacterial static and viral static activity, comprising:

oral dosing of a mammal with an anti-bacterial and antiviral effective amount of a treated, isolated and neutralized IgG fraction that has a molecular weight of about 55,000, which has been treated by acid hydrolysis, heated from 15 minutes to 1.0 hour at a temperature of 35° C. to 40° C. and thereafter neutralized back to a pH of about 7.

2. The method of claim 1 wherein the amount dosed is sufficient to provide a dosage of 0.25 mg/ml in the mammal's gut.

3. The method of claim 1 wherein the dose is up to 5 grams/day.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2002
From: APC COMPANY, INC.
To: LAURIDSEN GROUP, INC., THE
Reel/Frame 012677/0394 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2001
From: YODER, RALPH D.; STROHBEHN, RONALD E.
To: APC COMPANY
Reel/Frame 012000/0982 →
Continuity (1)
Related Publication 20020143157A1 · Oct 3, 2002